27 min listen
Is the Future of the Benign Hematology Consult Electronic? With Drs. Stephan Moll and Ashok Pai
FromThe Hematologist
Is the Future of the Benign Hematology Consult Electronic? With Drs. Stephan Moll and Ashok Pai
FromThe Hematologist
ratings:
Length:
28 minutes
Released:
Sep 1, 2019
Format:
Podcast episode
Description
In this podcast, Contributing Editor Dr. Stephan Moll has a conversation with Dr. Ashok Pai. They discuss Dr. Moll's Diffusion article from the September/October 2019 issue of The Hematologist. The article titled, "Is the Future of the Benign Hematology Consult Electronic?," discusses a virtual nonmalignant hematology consultation service, or e-consult, as a promising new approach that maximizes access to nonmalignant hematology expertise. You can find his Diffusion article online at www.hematology.org/Thehematologist/Diffusion/9802.aspx.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Sep 1, 2019
Format:
Podcast episode
Titles in the series (100)
BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia: In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or sm by The Hematologist